| Autologous stem cell transplantation in autoimmune and rheumatic diseases: from the molecular background to clinical applications. | |
| | |
MedLine Citation:
|
PMID: 20132064 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Autoimmune diseases have a multifactorial origin. Because of disturbances of the immune system, autoreactive T and B cells target self-antigens, leading to permanent organ damage. Despite novel therapeutic protocols, the disease course is chronic and in many instances the outcome is lethal. The efficacy of stem cell therapy has been observed in autoimmune animal models and in autoimmune diseases related to haematological abnormalities. Although the therapy is more than 30 years old, its broad spread has been delayed by the serious side-effects due to the conditioning treatments based on oncological protocols. Evaluation of the data of patients who have undergone autologous stem cell therapy reinforced the view that protocols used for conditioning treatments, mostly causing lymphoablation, and procedures carried out in specialist centres significantly reduced mortality, with an almost optimal therapeutical efficacy. New, multicentre investigations have been launched to compare the efficacy of various protocols. In this review, we summarize certain aspects of the molecular background of autologous stem cell transplantation and also depict the response to therapy in various autoimmune and rheumatic diseases. |
| | |
Authors:
|
P Szodoray; L Varoczy; G Szegedi; M Zeher |
Related Documents
:
|
19815104 - Bone involvement in clusters of autoimmune diseases: just a complication? 17261794 - Genetic control of immune response in carriers of ancestral haplotype 8.1: the study of... 9292954 - A patient with graves' disease, myasthenia gravis, and polymyositis. 21189704 - Intractable seizures and metabolic bone disease secondary to celiac disease. 21908864 - Dissection of human mirna regulatory influence to subpathway. 9833614 - The classification of gestational trophoblastic disease: a critical review. |
Publication Detail:
|
Type: Comparative Study; Journal Article; Review |
Journal Detail:
|
Title: Scandinavian journal of rheumatology Volume: 39 ISSN: 1502-7732 ISO Abbreviation: Scand. J. Rheumatol. Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-02-05 Completed Date: 2010-03-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0321213 Medline TA: Scand J Rheumatol Country: England |
Other Details:
|
Languages: eng Pagination: 1-11 Citation Subset: IM |
Affiliation:
|
Division of Clinical Immunology, 3rd Department of Medicine, Medical and Health Science Centre, University of Debrecen, Debrecen, Hungary. szodoray@gmail.com |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Antigens, CD34 / immunology, therapeutic use* Arthritis, Juvenile Rheumatoid / immunology, surgery Arthritis, Rheumatoid / immunology, mortality, surgery Autoimmune Diseases / diagnosis, mortality, therapy* Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Disease Models, Animal Female Follow-Up Studies Graft Rejection Graft Survival Hematopoietic Stem Cell Transplantation / methods* Humans Male Molecular Biology Randomized Controlled Trials as Topic Rheumatic Diseases / diagnosis, immunology, mortality, therapy* Survival Rate Transplantation, Autologous Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antigens, CD34 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Enhancing adoptive immunotherapy of cancer.
Next Document: Can disease-modifying anti-rheumatic drugs be discontinued in long-standing rheumatoid arthritis? A ...